Rajesh C. Shrotriya MD - 16 Feb 2021 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Director
Signature
/s/ Rajesh Shrotriya
Issuer symbol
GTBP
Transactions as of
16 Feb 2021
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:13:36 UTC
Previous filing
14 Feb 2022
Next filing
16 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50,000 $0.000000 50,000 16 Feb 2021 Common Stock 50,000 $6.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the shares vest on February 16, 2021, 2022 and 2023.